Methyl 3-oxocyclopentanecarboxylate, 97.0%, 500g

2-Chloro-4-formylbenzoic acid, 97%, 5g

(2R,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride, 98%, 50mg

4-n-Butylthiophenol, 97.0%, 250mg

4-tert-Butylbenzoylacetonitrile, 96.0%, 2.5g

Colonna capillare per GC ROTI®Cap-1701, 25 m, 0.32 mm, 1.00 µm, 1 Pezzo(i)

4-(4-Fluoro-phenylsulfanyl)-piperidine hydrochloride, 95.0%, 1g

Tert-butyl 4-(2-methylbut-3-yn-2-yl)piperazine-1-carboxylate, 95%, 100mg

2-Ethoxy-4-fluorobenzaldehyde, 97.0%, 1g

(S)-tert-Butyl 3-(bromomethyl)piperidine-1-carboxylate, 95.0%, 25g

Tetrahexylammonium Hydrogen Sulfate>98.0%(T)(N)5g

(2,4-Dimethylphenyl)(phenyl)methanamine hydrochloride, 98%, 100mg

tert-Butyl (4-bromo-2,3-dihydro-1H-inden-1-yl)carbamate, 97%, 250mg